IMMUNOCORE, LLC

Conshohocken, PA, United States

1

Total Recalls

0

Class I Recalls

1

Ongoing Recalls

Recalls by IMMUNOCORE, LLC

FDA Drug Class II Ongoing

KIMMTRAK (tebentafusp-tebn) Injection, 100 mcg/0.5 mL, For intravenous Infusion After Dilution, Single-Does vial. Mfd by: Immunocore Limited, 92 Park Drive, Abingdon, Oxfordshire, OX14 4RY, United Kin

June 10, 2025 IMMUNOCORE, LLC 7,572 vials units